Form 4 holding
Chief Executive Officer and Chief Financial Officer, Director
Spero Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 946,000
- Estimated value
- $983,840
- Report date
- 09 Nov 2026
- Price
- $1.04
- Ownership
- Direct